Payal D. Shah

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

Nadine Tung, Mark E. Robson, Steffen Ventz et al. · Journal of Clinical Oncology · 2020 · 500 citations

Medicine, Oncology, Pharmacology +16

Mutational spectrum in a worldwide study of 29,700 families with<i>BRCA1</i>or<i>BRCA2</i>mutations

Timothy R. Rebbeck, Tara M. Friebel, Eitan Friedman et al. · Human Mutation · 2018 · 314 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline

Isabelle Bedrosian, Mark R. Somerfield, Maria Isabel Achatz et al. · Journal of Clinical Oncology · 2024 · 179 citations

Medicine, Genetics, Oncology +17

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction

Biniyam G. Demissei, Rebecca A. Hubbard, Liyong Zhang et al. · Journal of the American Heart Association · 2020 · 163 citations · Full text

Medicine, Cardiology, Oncology +17

Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors

Pedram Razavi, Maura N. Dickler, Payal D. Shah et al. · Nature Cancer · 2020 · 162 citations

Medicine, Molecular Medicine, Pharmacology +10